FDA’s Marketing Denial Order Issued to Bidi Vapor’s Non-Tobacco Flavored ENDS Products are Set Aside and Remanded by the 11th Circuit Court of Appeals for being Arbitrary and Capricious (JSON)

lexblog.com/lib/36PVFKZCview recordjson

{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "FDA’s Marketing Denial Order Issued to Bidi Vapor’s Non-Tobacco Flavored ENDS Products are Set Aside and Remanded by the 11th Circuit Court of Appeals for being Arbitrary and Capricious",
    "url": "https://www.lexblog.com/2022/08/24/fdas-marketing-denial-order-issued-to-bidi-vapors-non-tobacco-flavored-ends-products-are-set-aside-and-remanded-by-the-11th-circuit-court-of-appeals-for-being-arbitrary-and-capriciou/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-36PVFKZC",
        "url": "https://www.lexblog.com/lib/36PVFKZC/"
    },
    "datePublished": "2022-08-24T15:44:32-04:00",
    "dateModified": "2022-08-24T12:44:56-04:00",
    "author": {
        "@type": "Person",
        "name": "Azim Chowdhury, Eric P. Gotting"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Keller Heckman"
    },
    "organizationScope": "at-publication",
    "isPartOf": "The Continuum of Risk",
    "about": "Administrative and Regulatory · Health Care and Life Sciences",
    "sourceUrl": "https://www.thecontinuumofrisk.com/?p=2916",
    "sourceStability": "may-move"
}